Page 13 - SPEMD_59-4

rev port estomatol med dent cir maxilofac . 2018;59(4):181-190 185

Table 2. Association between different classes of SRH and SROH for patients with type 2 diabetes mellitus (DM2) and
controls (nDM2)
How do you rate your oral health?
How do you rate your very bad or bad median good or very good p
general health?
very bad or bad 46 (34.6%) 27 a,b (21.6%) 10 (15.4%) <0.001
b
a
nDM2 median 56 (42.1%) 53 (42.4%) 17 (26.2%)
a
good or very good 31 (23.3%) 45b (36%) 38 (58.5%)
b
b
b
a
very bad or bad 85 (53.1%) 30 (29.7%) 25 (30.5%)
DM2 median 51 (31.9%) 47 (46.5%) 37 (45.1%) 0.001
good or very good 24 (15%) 24 (23.8%) 20 (24.4%)
p-values according to the chi-square test. a, b different letters indicate significantly different counts according to the Bonferroni method.
Table 3. Statistics (median and interquartile range; the lower the median value, the lower the self-perceived positive
impacts on health) regarding the self-perceived impacts (from very bad=1 to very good=5) of general health and oral
health for the control (nDM2) and the DM2 groups, considering several socio-demographic and clinical (general health
and oral health) variables.
How do you rate the perceived status How do you rate the perceived status
of your general health? of your oral health?
nDM2 DM2 nDM2 DM2
p p
n Me (P25-P75) n Me (P25-P75) Me (P25-P75) Me (P25-P75)
a
b
Female 203 3 (2-4) 176 3 (2-3) <0.001 3 (2-3) 3 (2-3) 0.321
a
b
Gender Male 120 3 (3-4) 167 3 (2-3) <0.001 3 (2-3) 3 (2-4) 0.894
0.353 0.869 0.182 0.365
a
b
< 65 years 196 3 (3-4) 114 3 (2-3.25) 0.002 3 (2-3) 3 (2-3.25) 0.669
a
b
Age ≥ 65 years 127 3 (2-4) 229 3 (2-3) 0.002 3 (2-3) 3 (2-3) 0.457
0.081 0.159 0.987 0.947
General Health
Low weight or normal 125 3 (3-4) 53 3 (2-4) 0.050 3 (2-3) 3 (2-3.5) 0.595
b
Pre-obese 123 3 (3-4) 163 3 (2-3) <0.001 3 (2-3) 3 (2-3) 0.532
a
BMI Obese 75 3 (2-4) 127 3 (2-3) 0.293 3 (2-3) 3 (2-3) 0.560
0.115 0.129 0.493 0.970
b
a
No 261 3 (3-4) 319 3 (2-3) <0.001 3 (2-3) 3 (2-4) 0.963
Smoker Yes 62 3 (2-4) 24 3 (2-4) 0.689 3 (2-3) 2 (1-3) 0.013
0.910 0.355 0.731 0.108
a
b
No 323 3 (2-4) 319 3 (2-3) <0.001 3 (2-3) 3 (2-3) 0.764
Neuropathy Yes 0 24 2 (1-3) n.a. 2 (1.25-3) n.a.
n.a. 0.504 n.a. 0.267
b
a
No 323 3 (2-4) 303 3 (2-3) <0.001 3 (2-3) 3 (2-3) 0.917
Retinopathy Yes 0 40 2 (1-2) n.a. 2 (2-3) n.a.
n.a. 0.148 n.a. 0.416
a
b
No 321 3 (2-4) 319 3 (2-3) <0.001 3 (2-3) 3 (2-3) 0.620
Nephropathy Yes 2 3 (3-3) 24 2 (1-3) 0.302 2 (2-2) 2 (1.25-3) 0.677
0.760 0.231 0.863 0.906
No 214 3 (3-4) 159 3 (2-4) 0.638 3 (2-3) 3 (2-4) 0.758
A
a
Bb
HTA Yes 109 3 (2-4) 184 2 (2-3) <0.001 3 (2-3) 3 (2-3) 0.753
0.994 <0.001 0.898 0.706
A
No 306 3 (2-4) 44 3 (2-4) 0.369 3 (2-3) 3 (2-3) 0.969
Dyslipidaemia Yes 16 3 (2-3.75) 299 3 (2-3) 0.186 2 (2-3) 3 (2-3) 0.381
B
0.532 <0.001 0.641 0.994
No 319 3 (2-4) 206 3 (2-4) 0.150 3 (2-3) 3 (2-3) 0.726
A
Controlled Yes 2 2.5 (2-3) 137 2 (2-3) 0.714 2.5 (2-3) 2 (2-3.5) 0.950
B
dyslipidaemia
0.768 <0.001 0.857 0.847
Controlled 103 2 (2-3) n.a. 2 (2-3) n.a.
B
A
HbA1c value Uncontrolled 240 3 (2-3) n.a. 3 (2-3.75) n.a.
<0.001 0.178
A
A
≤5 years 120 3 (2-3) n.a. 3 (2-4) n.a.
A
A
Duration of >5-10 years 109 3 (2-3) n.a. 3 (2-3.5) n.a.
B
B
DM2 >10 years 114 2 (2-3) n.a. 2 (2-3) n.a.
0.027 0.015
(continues on next page)